Birdwatch Archive

Birdwatch Note Rating

2024-12-30 05:20:36 UTC - NOT_HELPFUL

Rated by Participant: E5229628BF09929E96A58BF054BAC6E513F4CC9413D1712AD5F4F1F413FA3272
Participant Details

Original Note:

Vivek developed a drug for Alzheimer’s through a subsidiary of Roivant, Axovant. This drug failed, like most Alzheimer’s drugs. Vivek did not profit from it, choosing not to sell shares in Axovant before its collapse. Roivant also avoided such sales. Blatant lies in post. https://x.com/implisci/status/1697335207462883518

All Note Details

Original Tweet

All Information

  • noteId - 1873548470784610305
  • participantId -
  • raterParticipantId - E5229628BF09929E96A58BF054BAC6E513F4CC9413D1712AD5F4F1F413FA3272
  • createdAtMillis - 1735536036254
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1873548470784610305E5229628BF09929E96A58BF054BAC6E513F4CC9413D1712AD5F4F1F413FA3272